MarketBeat’s proprietary stock screener tool selects seven AI-focused equities—Super Micro Computer (SMCI), Salesforce (CRM), ServiceNow (NOW), Arista Networks (ANET), Accenture (ACN), QUALCOMM (QCOM), and Tempus AI (TEM)—by filtering for highest dollar trading volumes and key fundamental metrics, guiding intermediate investors toward sector momentum and potential returns.

Key points

  • Super Micro Computer (SMCI) traded 15.24 M shares mid-day, with P/E 16.37 and quick ratio 1.93.
  • Salesforce (CRM) saw 1.74 M volume at $273.78, with P/E 44.93, PEG 2.58, and current ratio 1.11.
  • Tempus AI (TEM) recorded 4.41 M volume at $53.15, debt/equity 8.17, and 50-day MA $47.95.

Q&A

  • What determines AI stock performance?
  • Why is trading volume important?
  • What is a PEG ratio?
  • How are quick and current ratios used?
Copy link
Facebook X LinkedIn WhatsApp
Share post via...


Read full article

Artificial Intelligence in Longevity Research

What is Artificial Intelligence? Artificial Intelligence (AI) refers to computer systems designed to perform tasks that typically require human intelligence, such as pattern recognition, decision-making, and language understanding. In longevity research, AI uses advanced algorithms and large datasets to uncover biological markers of aging, predict disease onset, and accelerate drug discovery.

Core AI Methods

  • Machine Learning: Algorithms learn from data to predict outcomes—for example, identifying gene expression patterns linked to lifespan.
  • Deep Learning: Neural networks with many layers process complex inputs like imaging and genomic sequences to detect subtle aging signatures.
  • Natural Language Processing: AI systems analyze scientific literature and clinical records to extract information on aging pathways and therapeutic candidates.

Data Sources Longevity research relies on diverse data types:

  • Genomic Data: DNA sequences and epigenetic profiles provide insights into genetic determinants of aging.
  • Transcriptomic and Proteomic Data: RNA and protein measurements reveal cellular responses over time.
  • Clinical Records: Patient health histories, biometrics, and lab tests track progression of age-related diseases.
  • Imaging Data: Microscopy and medical scans visualize tissue changes associated with aging.

Applications of AI in Longevity Science

  1. Biomarker Discovery: AI identifies molecular markers—such as DNA methylation patterns—that correlate with biological age more accurately than chronological age.
  2. Drug Repurposing: Machine learning models screen existing drugs for anti-aging properties by predicting interactions with longevity-related targets.
  3. Personalized Interventions: AI-driven risk models tailor lifestyle and treatment plans to individual aging profiles, improving preventive care.
  4. Clinical Trial Optimization: Smart algorithms select optimal patient cohorts and endpoints, reducing time and cost for aging-related trials.

Challenges and Best Practices

Although powerful, AI models must contend with data quality issues, interpretability, and ethical considerations. Best practices include rigorous validation with independent datasets, transparent model reporting, and close collaboration between data scientists and biologists.

Future Directions: As computational power increases and multi-omics datasets grow, AI will become central to deciphering aging mechanisms and developing targeted longevity therapies, bringing us closer to extending healthy human lifespan.